🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to provide continued access to ixazomib and/or...
Status
Completed
Location
Multiple Locations
Start Date
2013-04-29
Trial ID
NCT01850524
Treatments Being Tested
This phase I/II trial studies the side effects and the best dose of cycloph...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2013-08-20
Trial ID
NCT01864018
This is a phase 1/2 study of a drug called Ixazomib in combination with cyt...
Status
Active Not Recruiting
Location
Children's Hospital Los Angeles
Start Date
2019-02-12
Trial ID
NCT03817320
The clinical trial was conducted in a cohort of young, high-risk myeloma pa...
Status
Unknown
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Start Date
2018-01-05
Trial ID
NCT04008888
This phase I/II trial studies the side effects and best dose of idasanutlin...
Status
Completed
Location
City of Hope Comprehensive Cancer Center
Start Date
2015-12-30
Trial ID
NCT02633059
Treatments Being Tested
The primary purpose of this study is to evaluate the anti-tumor activity of...
Status
Completed
Location
Multiple Locations
Start Date
2013-10-31
Trial ID
NCT01939899
Treatments Being Tested
This phase II trial studies how well ixazomib, gemcitabine, and doxorubicin...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2018-08-17
Trial ID
NCT03587662
The purpose of this study is to determine the efficacy of Ixazomib when com...
Status
Withdrawn
Location
University of Arkansas for Medical Science
Start Date
2015-12
Trial ID
NCT02578121
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability, maximum...
Status
Completed
Location
UCSF Medical Center
Start Date
2011-10-31
Trial ID
NCT01383928
Treatments Being Tested
This randomized phase II trial studies how well lenalidomide alone compared...
Status
Completed
Location
University of Chicago
Start Date
2015-03-02
Trial ID
NCT02389517
Treatments Being Tested